In 1996, Vertongen et al. [134] reported that PACAP significantly decreased proliferation of T98G human glioma cells; conversely, Sokolowska and Nowak (2008) [135] demonstrated that this peptide enhanced mouse C6 glioma cell proliferation after its exogenous administration. The gene discussed is ADCYAP1; the disease is central nervous system cancer.